AAAAAA

   
Results: 1-23 |
Results: 23
A novel psychophysiological therapy for the treatment of hypertension: Analysis of a 16-year case study
Authors: Craig, FW Lynch, JJ Rosch, PJ Rasey, HW
Citation: Fw. Craig et al., A novel psychophysiological therapy for the treatment of hypertension: Analysis of a 16-year case study, ALTERN TH H, 7(1), 2001, pp. 96
Screening mammography and breast cancer treatment patterns in older women
Authors: Kerner, JF Mandelblatt, JS Silliman, RA Lynch, JJ Senie, R Cohen, C Hwang, YT
Citation: Jf. Kerner et al., Screening mammography and breast cancer treatment patterns in older women, BREAST CANC, 69(1), 2001, pp. 81-91
Management of malignant pineal germ cell tumors with residual mature teratoma
Authors: Friedman, JA Lynch, JJ Buckner, JC Scheithauer, BW Raffel, C
Citation: Ja. Friedman et al., Management of malignant pineal germ cell tumors with residual mature teratoma, NEUROSURGER, 48(3), 2001, pp. 518-522
Functional role of alpha-calcitonin gene-related peptide in the regulationof the cardiovascular system
Authors: Shen, YT Pittman, TJ Buie, PS Bolduc, DL Kane, SA Koblan, KS Gould, RJ Lynch, JJ
Citation: Yt. Shen et al., Functional role of alpha-calcitonin gene-related peptide in the regulationof the cardiovascular system, J PHARM EXP, 298(2), 2001, pp. 551-558
Calcitonin and spinal fusion
Authors: Theodore, N Lynch, JJ
Citation: N. Theodore et Jj. Lynch, Calcitonin and spinal fusion, J NEUROSURG, 94(2), 2001, pp. 339-339
Design and biological activity of (S)-4-(5-{[1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency
Authors: Bell, IM Gallicchio, SN Abrams, M Beshore, DC Buser, CA Culberson, JC Davide, J Ellis-Hutchings, M Fernandes, C Gibbs, JB Graham, SL Hartman, GD Heimbrook, DC Homnick, CF Huff, JR Kassahun, K Koblan, KS Kohl, NE Lobell, RB Lynch, JJ Miller, PA Omer, CA Rodrigues, AD Walsh, ES Williams, TM
Citation: Im. Bell et al., Design and biological activity of (S)-4-(5-{[1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl}imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency, J MED CHEM, 44(18), 2001, pp. 2933-2949
Synchronization of oscillators coupled through narrow-band networks
Authors: Lynch, JJ York, RA
Citation: Jj. Lynch et Ra. York, Synchronization of oscillators coupled through narrow-band networks, IEEE MICR T, 49(2), 2001, pp. 237-249
Platelet glycoprotein IIb/IIIa receptor inhibitor preserves coronary flow reserve during progressive coronary arteriostenosis in swine
Authors: Shen, YT Wiedmann, RT Lynch, JJ Gould, RJ
Citation: Yt. Shen et al., Platelet glycoprotein IIb/IIIa receptor inhibitor preserves coronary flow reserve during progressive coronary arteriostenosis in swine, ART THROM V, 20(10), 2000, pp. 2309-2315
Arrhythmogenic potential of positive inotropic agents
Authors: Stump, GL Wallace, AA Gilberto, DB Gehret, JR Lynch, JJ
Citation: Gl. Stump et al., Arrhythmogenic potential of positive inotropic agents, BAS R CARD, 95(3), 2000, pp. 186-198
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat
Authors: Kowaluk, EA Mikusa, J Wismer, CT Zhu, CZ Schweitzer, E Lynch, JJ Lee, CH Jiang, MQ Bhagwat, SS Gomtsyan, A McKie, J Cox, BF Polakowski, J Reinhart, G Williams, M Jarvis, MF
Citation: Ea. Kowaluk et al., ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat, J PHARM EXP, 295(3), 2000, pp. 1165-1174
ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain
Authors: Jarvis, MF Wessale, JL Zhu, CZ Lynch, JJ Dayton, BD Calzadilla, SV Padley, RJ Opgenorth, TJ Kowaluk, EA
Citation: Mf. Jarvis et al., ABT-627, an endothelin ETA receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain, EUR J PHARM, 388(1), 2000, pp. 29-35
Chronic therapy with an ETA/B receptor antagonist in conscious dogs duringprogression of congestive heart failure - Intracellular Ca2+ regulation and nitric oxide mediated coronary relaxation
Authors: Shen, YT Buie, PS Lynch, JJ Krause, SM Ma, XL
Citation: Yt. Shen et al., Chronic therapy with an ETA/B receptor antagonist in conscious dogs duringprogression of congestive heart failure - Intracellular Ca2+ regulation and nitric oxide mediated coronary relaxation, CARDIO RES, 48(2), 2000, pp. 332-345
Patterns of breast carcinoma treatment in older women - Patient preferenceand clinical and physician influences
Authors: Mandelblatt, JS Hadley, J Kerner, JF Schulman, KA Gold, K Dunmore-Griffith, J Edge, S Guadagnoli, E Lynch, JJ Meropol, NJ Weeks, JC Winn, R
Citation: Js. Mandelblatt et al., Patterns of breast carcinoma treatment in older women - Patient preferenceand clinical and physician influences, CANCER, 89(3), 2000, pp. 561-573
Conditioned feeding responses in sheep to flavoured foods associated with sulphur doses
Authors: Hills, J Kyriazakis, I Nolan, JV Hinch, GN Lynch, JJ
Citation: J. Hills et al., Conditioned feeding responses in sheep to flavoured foods associated with sulphur doses, ANIM SCI, 69, 1999, pp. 313-325
Grass odor and flavor overcome feed neophobia in sheep
Authors: Van Tien, D Lynch, JJ Hinch, GN Nolan, JV
Citation: D. Van Tien et al., Grass odor and flavor overcome feed neophobia in sheep, SMALL RUMIN, 32(3), 1999, pp. 223-229
EXP3174, the AII antagonist human metabolite of losartan, but not losartannor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction
Authors: Lynch, JJ Stump, GL Wallace, AA Painter, CA Thomas, JM Kusma, SE Gould, RJ Grossman, W
Citation: Jj. Lynch et al., EXP3174, the AII antagonist human metabolite of losartan, but not losartannor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction, J AM COL C, 34(3), 1999, pp. 876-884
A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs
Authors: Shen, YT Lynch, JJ Shannon, RP Wiedmann, RT
Citation: Yt. Shen et al., A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs, AM J P-HEAR, 46(1), 1999, pp. H388-H398
Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice
Authors: Kowaluk, EA Kohlhaas, KL Bannon, A Gunther, K Lynch, JJ Jarvis, MF
Citation: Ea. Kowaluk et al., Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice, PHARM BIO B, 63(1), 1999, pp. 83-91
Antithrombotic efficacy of thrombin inhibitor L-374,087: Intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis
Authors: Cook, JJ Gardell, SJ Holahan, MA Sitko, GR Stump, GL Wallace, AA Gilberto, DB Hare, TR Krueger, JA Dyer, DL Sanderson, PEJ Vacca, JP Shafer, JA Lynch, JJ
Citation: Jj. Cook et al., Antithrombotic efficacy of thrombin inhibitor L-374,087: Intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis, J PHARM EXP, 289(1), 1999, pp. 503-510
Development of postoperative fibromatosis after resection of an intraspinal meningioma - Case report
Authors: Lynch, JJ Parvizi, J Scheithauer, BW Krauss, WE
Citation: Jj. Lynch et al., Development of postoperative fibromatosis after resection of an intraspinal meningioma - Case report, J NEUROSURG, 90(1), 1999, pp. 121-124
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. (vol 42, pg 2409, 1999)
Authors: Egbertson, MS Cook, JJ Bednar, B Prugh, JD Bednar, RA Gaul, SL Gould, RJ Hartman, GD Homnick, CF Holahan, MA Libby, LA Lynch, JJ Lynch, RJ Sitko, GR Stranieri, MT Vasallo, LM
Citation: Ms. Egbertson et al., Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation. (vol 42, pg 2409, 1999), J MED CHEM, 42(19), 1999, pp. 4014-4014
Non-peptide GPIIb IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation
Authors: Egbertson, MS Cook, JJ Bednar, B Prugh, JD Bednar, RA Gaul, SL Gould, RJ Hartman, GD Homnick, CF Holahan, MA Libby, LA Lynch, JJ Lynch, RJ Sitko, GR Stranieri, MT Vassallo, LM
Citation: Ms. Egbertson et al., Non-peptide GPIIb IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation, J MED CHEM, 42(13), 1999, pp. 2409-2421
Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I-Ks, in canine models of malignant ischemic ventricular arrhythmia
Authors: Lynch, JJ Houle, MS Stump, GL Wallace, AA Gilberto, DB Jahansouz, H Smith, GR Tebben, AJ Liverton, NJ Selnick, HG Claremon, DA Billman, GE
Citation: Jj. Lynch et al., Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I-Ks, in canine models of malignant ischemic ventricular arrhythmia, CIRCULATION, 100(18), 1999, pp. 1917-1922
Risultati: 1-23 |